Clinical Trial Details
EORTC-30061
Back to Clinical Trials Database
Phase I study of cisplatin, gemcitabine (+ paclitaxel) and lapatinib as first line treatment in advanced/metastatic urothelial cancer
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 23-Nov-2007 Date Step1 close: 17-Apr-2012 |
| Data management at EORTC | Yes |
| Design |
Phase 1 Randomized open label |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00623064 |
| NCT number | NCT00623064 |
| EudraCT | 2006-002976-16 |
